Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
1.1800
-0.1040
(-8.10%)
As of 1:18:08 PM GMT+1. Market Open.
Earnings Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | 7 | 4 |
| Avg. Estimate | -- | -- | 184.9M | 227.8M |
| Low Estimate | -- | -- | 181M | 222M |
| High Estimate | -- | -- | 197.4M | 237M |
| Year Ago Sales | -- | -- | 169.67M | 184.9M |
| Sales Growth (year/est) | -- | -- | 8.98% | 23.20% |
EPS Trend
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 4R0.F | -- | -- | -- | -- |
| S&P 500 | 16.04% | 7.30% | 10.62% | 14.21% |
Related Tickers
BV3A.F Bavarian Nordic A/S
7.25
-2.68%
ZVA.F Cellectis S.A.
1.2780
-0.62%
22Z.F Zealand Pharma A/S
80.30
-0.93%
AYJ.F Valneva SE
3.2820
-3.47%
CVAC CureVac N.V.
3.0800
-0.65%
ALNY Alnylam Pharmaceuticals, Inc.
243.53
-1.30%
RVMD Revolution Medicines, Inc.
38.34
-5.89%
MESO Mesoblast Limited
15.41
-10.15%
BEAM Beam Therapeutics Inc.
25.10
-4.71%
AXSM Axsome Therapeutics, Inc.
127.15
-0.31%